Bloomberg reported that Teva Pharmaceutical Industries Ltd. bought 1.35 percent of Mylan stock, putting pressure on the company to accept a takeover offer.
“Acquiring shares of Mylan underscores our commitment to consummating a transaction as soon as possible,” Teva said in a statement. Read the Bloomberg article
